These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 7598139)

  • 1. Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women.
    Denke MA
    Am J Med; 1995 Jul; 99(1):29-35. PubMed ID: 7598139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
    Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
    Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent use of simvastatin and estrogen--progestin therapy compared with each therapy alone for hypercholesterolemia in postmenopausal women.
    Darling GM; Johns JA; McCloud PI; Davis SR
    Climacteric; 1999 Sep; 2(3):181-8. PubMed ID: 11910595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual responsiveness to a cholesterol-lowering diet in postmenopausal women with moderate hypercholesterolemia.
    Denke MA
    Arch Intern Med; 1994 Sep; 154(17):1977-82. PubMed ID: 8074602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
    Sbarouni E; Kyriakides ZS; Kremastinos DTh
    J Am Coll Cardiol; 1998 Nov; 32(5):1244-50. PubMed ID: 9809932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
    Vigna GB; Donegà P; Zanca R; Barban A; Passaro A; Pansini F; Bonaccorsi G; Mollica G; Fellin R
    Metabolism; 2002 Nov; 51(11):1463-70. PubMed ID: 12404199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
    Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive meta-analysis of the effects of oral medroxyprogesterone acetate plus conjugated equine oestrogens on the lipid profile in women: Insights from randomized controlled trials.
    Zhang YL; Xie L; Wu FL; Ding X; Hernández-Wolters B; Găman MA; Kord-Varkaneh H
    Eur J Clin Invest; 2024 Aug; 54(8):e14211. PubMed ID: 38726889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement and simvastatin in the therapy of hypercholesterolemic postmenopausal women.
    Averbuch M; Ayalon D; Eckstein N; Dotan I; Shapira I; Levo Y; Pines A
    J Med; 1998; 29(5-6):343-50. PubMed ID: 10503169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia.
    Denke MA; Grundy SM
    Arch Intern Med; 1994 Feb; 154(3):317-25. PubMed ID: 8297199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
    Sendag F; Karadadas N; Ozsener S; Bilgin O
    Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of adding C-19 versus C-21 progestin to conjugated estrogen in moderately hypercholesterolemic postmenopausal women.
    Wolfe BM; Koval JJ; Nisker JA
    Am J Obstet Gynecol; 1998 Apr; 178(4):787-92. PubMed ID: 9579445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.
    Darling GM; Johns JA; McCloud PI; Davis SR
    N Engl J Med; 1997 Aug; 337(9):595-601. PubMed ID: 9271481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of continuous combined hormone replacement therapy, HMG-CoA reductase inhibitor and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Ozsener S; Sendag F; Koc T; Terek MC; Oztekin K; Bilgin O
    J Obstet Gynaecol Res; 2001 Dec; 27(6):353-8. PubMed ID: 11794823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.
    Pickar JH; Wild RA; Walsh B; Hirvonen E; Lobo RA
    Climacteric; 1998 Mar; 1(1):26-32. PubMed ID: 11913407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial.
    Binder EF; Williams DB; Schechtman KB; Jeffe DB; Kohrt WM
    Ann Intern Med; 2001 May; 134(9 Pt 1):754-60. PubMed ID: 11329233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of hormone replacement therapy on plasma lipids in type II diabetes.
    Manwaring P; Morfis L; Diamond T; Howes LG
    Maturitas; 2000 Mar; 34(3):239-47. PubMed ID: 10717490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
    Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
    J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.